MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

Projekter: ProjektForskning

Beskrivelse

22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease (cirrhosis). We aim to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional liver (decompensated cirrhosis), when such decompensated cirrhosis will progress to acute-on-chronic liver failure (ACLF), and a patient’s individual treatment response. Based on such biomarkers, we strive to develop novel diagnostic tools for earlier and better patient stratification and to establish personalised and effective treatment strategies.
AkronymMicrob-Predict
StatusIgangværende
Effektiv start/slut dato01/01/201931/03/2025